{"addison's disease": 15.04, "adrenal disorder": 25.87, "adrenal insufficiency": 105.85, "adrenocortical insufficiency acute": 30.03, "adrenocorticotropic hormone deficiency": 297.17, "alanine aminotransferase increased": 2.23, "amylase increased": 5.68, "arthritis": 2.08, "aspartate aminotransferase increased": 2.36, "autoimmune colitis": 100.22, "autoimmune haemolytic anaemia": 4.55, "autoimmune hepatitis": 28.63, "autoimmune pancreatitis": 40.29, "autoimmune thyroiditis": 10.75, "blood corticotrophin decreased": 66.75, "blood creatine phosphokinase increased": 2.12, "blood thyroid stimulating hormone abnormal": 21.84, "blood thyroid stimulating hormone decreased": 9.62, "blood thyroid stimulating hormone increased": 3.46, "bronchopulmonary aspergillosis": 2.68, "c-reactive protein increased": 3.11, "central hypothyroidism": 11.67, "cholangitis": 9.83, "cholangitis sclerosing": 21.76, "cholecystitis": 3.26, "cholestasis": 2.98, "chronic gastritis": 3.85, "colitis": 47.14, "colitis microscopic": 4.08, "coronavirus infection": 3.21, "cortisol decreased": 20.04, "cytokine release syndrome": 11.14, "cytomegalovirus enterocolitis": 12.75, "decreased appetite": 2.69, "dermatitis": 3.83, "dermatitis psoriasiform": 6.54, "diabetic ketoacidosis": 4.11, "disseminated intravascular coagulation": 5.82, "drug eruption": 5.02, "drug-induced liver injury": 4.73, "duodenitis": 9.45, "dyslalia": 5.58, "encephalitis": 11.1, "encephalitis autoimmune": 14.62, "endocrine disorder": 20.46, "enteritis": 7.19, "enterocolitis": 28.62, "eosinophil count increased": 5.73, "eosinophilia": 2.17, "erythema multiforme": 7.19, "eyelid ptosis": 6.04, "febrile neutropenia": 2.65, "fulmit type 1 diabetes mellitus": 169.17, "gastritis": 2.29, "gastrointestinal perforation": 3.43, "general physical health deterioration": 2.29, "glucocorticoid deficiency": 28.47, "graves' disease": 3.65, "guillain-barre syndrome": 3.46, "haemophagocytic lymphohistiocytosis": 16.95, "hair colour changes": 2.17, "hepatic cytolysis": 5.93, "hepatic failure": 2.07, "hepatic function abnormal": 9.21, "hepatitis": 11.7, "hepatitis acute": 2.89, "hepatitis fulmit": 4.75, "hepatotoxicity": 4.79, "hypercalcaemia": 2.67, "hyperlipasaemia": 12.9, "hyperthyroidism": 18.0, "hypertransaminasaemia": 2.5, "hyponatraemia": 2.09, "hypophysitis": 166.5, "hypopituitarism": 211.67, "hypothalamo-pituitary disorder": 58.84, "hypothyroidism": 22.94, "immune thrombocytopenia": 2.77, "immune-mediated adrenal insufficiency": 221.13, "immune-mediated adverse reaction": 114.08, "immune-mediated arthritis": 90.98, "immune-mediated cholangitis": 55.04, "immune-mediated dermatitis": 312.99, "immune-mediated encephalitis": 67.83, "immune-mediated endocrinopathy": 124.02, "immune-mediated enterocolitis": 143.18, "immune-mediated gastritis": 71.59, "immune-mediated hepatic disorder": 208.95, "immune-mediated hepatitis": 88.46, "immune-mediated hyperthyroidism": 51.29, "immune-mediated hypophysitis": 132.14, "immune-mediated hypothyroidism": 52.9, "immune-mediated lung disease": 120.32, "immune-mediated myasthenia gravis": 39.74, "immune-mediated myocarditis": 57.5, "immune-mediated myositis": 49.96, "immune-mediated nephritis": 99.0, "immune-mediated pancreatitis": 108.4, "immune-mediated renal disorder": 91.81, "immune-mediated thyroiditis": 87.17, "immune-mediated uveitis": 55.42, "infectious pleural effusion": 8.15, "infusion related reaction": 4.93, "intentional product use issue": 20.81, "interstitial lung disease": 16.07, "intestinal perforation": 3.73, "large intestine perforation": 4.06, "leukoderma": 213.88, "lichenoid keratosis": 5.99, "lipase increased": 3.35, "liver disorder": 12.88, "lung disorder": 2.12, "lung opacity": 5.51, "lymphangiosis carcinomatosa": 11.34, "lymphocytic hypophysitis": 111.76, "maligt neoplasm progression": 26.97, "maligt pleural effusion": 8.02, "meningitis": 5.1, "meningitis aseptic": 9.09, "metastases to bone": 4.26, "metastases to central nervous system": 13.64, "metastases to liver": 3.36, "metastases to lung": 4.74, "metastases to lymph nodes": 5.45, "metastases to meninges": 6.02, "metastases to spine": 5.66, "metastatic maligt melanoma": 5.52, "myasthenia gravis": 21.11, "myasthenic syndrome": 11.13, "myocarditis": 5.99, "myositis": 24.57, "nephritis": 14.73, "neuropathy peripheral": 2.64, "neutrophil count decreased": 3.32, "non-small cell lung cancer": 378.13, "oesophagitis": 2.59, "organising pneumonia": 10.63, "pancreatic enzymes increased": 7.25, "pemphigoid": 3.84, "performance status decreased": 3.07, "peripheral sensory neuropathy": 3.67, "physical deconditioning": 3.62, "pituitary enlargement": 75.93, "pleural effusion": 3.04, "pneumocystis jirovecii pneumonia": 3.48, "pneumonia aspiration": 3.16, "pneumonia bacterial": 7.11, "pneumonitis": 22.52, "polyarthritis": 3.5, "polymyalgia rheumatica": 6.9, "polymyositis": 8.37, "prescribed overdose": 5.35, "prescribed underdose": 5.22, "primary adrenal insufficiency": 40.84, "pulmonary toxicity": 16.9, "radiation pneumonitis": 30.12, "rash": 2.5, "rash maculo-papular": 2.54, "renal disorder": 3.23, "renal impairment": 2.36, "sarcoidosis": 4.63, "secondary adrenocortical insufficiency": 218.92, "sialoadenitis": 9.76, "silent thyroiditis": 170.19, "sjogren's syndrome": 4.04, "skin disorder": 7.57, "skin toxicity": 6.03, "stevens-johnson syndrome": 2.39, "thrombophlebitis migrans": 36.15, "thyroid disorder": 15.1, "thyroiditis": 68.82, "thyrotoxic crisis": 13.68, "toxic epidermal necrolysis": 2.98, "troponin increased": 2.51, "tubulointerstitial nephritis": 9.97, "tumour haemorrhage": 7.51, "tumour lysis syndrome": 3.82, "tumour pseudoprogression": 57.44, "type 1 diabetes mellitus": 24.68, "uveitis": 8.08, "vitiligo": 12.48, "vogt-koyanagi-harada disease": 43.24}